Raise closed, search for fresh raises on Seedstage

Dallas, TX

Scaling a digital therapeutic platform that uses immersive technology to enhance mental health treatments.

• Innovative mental health treatment: Uses immersive technology to induce psychedelic states without substances.
• Clinically validated results: Studies show significant reductions in depression, anxiety, and stress.
• Strong market demand: Over 450 practitioners on the waitlist and successful beta deployment in 80+ practices.
• Non-drug alternative: Bypasses regulatory hurdles faced by traditional psychedelic treatments.
• Strategic market positioning: Positioned to scale in the growing mental health and digital therapeutics market.

SoundSelf offers a groundbreaking digital therapeutic solution designed to induce psychedelic states without the use of substances, providing mental health professionals with an innovative tool to enhance therapy. The platform uses biofeedback and immersive technology to amplify breath and vocal-toning meditation techniques, helping users achieve transformative mental health benefits. SoundSelf has been clinically validated as an effective adjunct to ketamine therapy, demonstrating significant reductions in depression, anxiety, and stress. With over 450 practitioners on the waitlist and successful beta deployment in 80+ therapeutic practices, SoundSelf is positioned to scale its impact across mental health clinics and therapeutic centers.

The funds raised will support expanding SoundSelf’s clinical reach, growing its sales team, and conducting further research to validate its efficacy in treating anxiety and depression. This investment round will also enable the company to educate clinics on best practices and standardize SoundSelf as an essential tool for ketamine therapy. By offering a scalable, non-drug alternative that bypasses regulatory hurdles faced by traditional psychedelics, SoundSelf is uniquely positioned to capture market share in the $44 billion mental health treatment industry. The company aims to extend its applications beyond ketamine therapy, with plans to seek FDA approval and become a leading platform in the digital therapeutics space.

Company Info

SoundSelf uses immersive technology to provide non-drug treatments for depression, anxiety, and PTSD, enhancing traditional therapies like ketamine.

SoundSelf is a pioneering digital therapeutic platform designed to help treat mental health disorders such as depression, anxiety, and PTSD using immersive technology, bypassing the need for substances. SoundSelf operates as a biofeedback system, combining game design and digital technology to induce psychedelic-like states that aid in the therapeutic process. The system is clinically proven to improve mental health outcomes, with studies showing significant reductions in depression and anxiety. It also enhances ketamine therapy, making it a valuable tool for clinics offering this treatment.

The platform has demonstrated its efficacy through studies and trials, including those conducted at university and clinical levels. SoundSelf’s product is currently in use in over 80 therapeutic practices, with 450 additional practitioners on the waitlist. The company has raised $2 million so far and plans to scale its operations, aiming to become a cornerstone of the mental health treatment landscape. With ongoing clinical studies, SoundSelf is positioning itself for future FDA approval and broader adoption within the mental health and wellness sector.